Cardiff Oncology (CRDF) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CRDF Stock Alerts $3.63 0.00 (0.00%) (As of 09:39 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cardiff Oncology Short Interest DataCurrent Short Volume4,420,000 sharesPrevious Short Volume3,990,000 sharesChange Vs. Previous Month+10.78%Dollar Volume Sold Short$19.27 millionShort Interest Ratio / Days to Cover2.3Last Record DateApril 30, 2024Outstanding Shares44,725,000 sharesPercentage of Shares Shorted9.88%Today's Trading Volume20,511 sharesAverage Trading Volume1,350,000 sharesToday's Volume Vs. Average2% Short Selling Cardiff Oncology ? Sign up to receive the latest short interest report for Cardiff Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCRDF Short Interest Over TimeCRDF Days to Cover Over TimeCRDF Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Cardiff Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,420,000 shares $19.27 million +10.8%N/A2.3 $4.36 4/15/20243,990,000 shares $21.07 million +17.0%N/A2.2 $5.28 3/31/20243,410,000 shares $18.21 million +21.4%N/A2 $5.34 3/15/20242,810,000 shares $14.13 million +144.4%N/A1.8 $5.03 2/29/20241,150,000 shares $2.03 million -3.4%N/A0.9 $1.77 2/15/20241,190,000 shares $2.08 million -7.8%N/A7.6 $1.75 Get the Latest News and Ratings for CRDF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,290,000 shares $2.01 million +13.2%N/A7.5 $1.56 1/15/20241,140,000 shares $1.93 million -13.6%N/A6.5 $1.69 12/31/20231,320,000 shares $1.95 million -2.2%N/A6.4 $1.48 12/15/20231,350,000 shares $1.89 million -6.9%N/A2 $1.40 11/30/20231,450,000 shares $1.78 million -9.4%N/A2.1 $1.23 11/15/20231,600,000 shares $1.94 million -1.8%N/A2.3 $1.21 10/31/20231,630,000 shares $1.74 million +6.5%N/A2.2 $1.07 10/15/20231,530,000 shares $1.70 million -24.6%N/A1.4 $1.11 9/30/20232,030,000 shares $2.82 million +201.6%N/A1.9 $1.39 9/15/2023673,000 shares $1.16 million +25.4%N/A1.1 $1.73 8/31/2023536,500 shares $987,160.00 -19.5%N/A0.9 $1.84 8/15/2023666,400 shares $1.33 million +28.7%N/A1.2 $2.00 7/31/2023517,700 shares $916,329.00 +5.0%N/A1 $1.77 7/15/2023492,900 shares $694,989.00 -8.2%N/A3.3 $1.41 6/30/2023537,000 shares $789,390.00 +1.0%N/A3.5 $1.47 6/15/2023531,600 shares $845,244.00 -1.7%N/A3.4 $1.59 5/31/2023541,000 shares $871,010.00 -0.2%N/A2.9 $1.61 5/15/2023542,300 shares $949,025.00 -12.1%N/A2.7 $1.75 4/30/2023616,900 shares $1.07 million -2.4%N/A2.9 $1.74 4/15/2023632,000 shares $941,680.00 +1.2%N/A3 $1.49 3/31/2023624,300 shares $1.03 million -7.3%N/A2.6 $1.65 3/15/2023673,600 shares $1.16 million -1.6%N/A2.6 $1.72 2/28/2023684,400 shares $1.18 million -14.6%N/A2.9 $1.73 2/15/2023801,300 shares $1.50 million -11.6%N/A3.3 $1.87 1/31/2023905,900 shares $1.62 million -9.4%N/A3.6 $1.79 1/15/20231,000,000 shares $1.53 million -8.3%N/A3.9 $1.53 12/30/20221,090,000 shares $1.53 million -5.2%N/A4.6 $1.40 12/15/20221,150,000 shares $1.61 million -2.5%N/A4.4 $1.40 11/30/20221,180,000 shares $1.88 million -1.7%N/A2.3 $1.59 11/15/20221,200,000 shares $1.61 million -7.7%N/A2.2 $1.34 10/31/20221,300,000 shares $2.12 million -19.8%N/A2.2 $1.63 10/15/20221,620,000 shares $2.49 million -10.0%N/A2.6 $1.54 9/30/20221,800,000 shares $2.77 million -18.2%N/A2.7 $1.54 9/15/20222,200,000 shares $3.67 million +9.5%N/A2.5 $1.67Does this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit CRDF Short Interest - Frequently Asked Questions What is Cardiff Oncology's current short interest? Short interest is the volume of Cardiff Oncology shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 4,420,000 shares of CRDF short. Learn More on Cardiff Oncology's current short interest. What is a good short interest ratio for Cardiff Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRDF shares currently have a short interest ratio of 2.0. Learn More on Cardiff Oncology's short interest ratio. Which institutional investors are shorting Cardiff Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cardiff Oncology: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cardiff Oncology's short interest increasing or decreasing? Cardiff Oncology saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 4,420,000 shares, an increase of 10.8% from the previous total of 3,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cardiff Oncology's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Cardiff Oncology: X4 Pharmaceuticals, Inc. (7.85%), Vaxart, Inc. (10.44%), Cellectis S.A. (1.18%), Cardiol Therapeutics Inc. (0.50%), Compugen Ltd. (2.25%), Vigil Neuroscience, Inc. (4.61%), Genfit S.A. (0.18%), Adverum Biotechnologies, Inc. (8.04%), Scilex Holding (8.38%), Omega Therapeutics, Inc. (22.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cardiff Oncology stock? Short selling CRDF is an investing strategy that aims to generate trading profit from Cardiff Oncology as its price is falling. CRDF shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cardiff Oncology? A short squeeze for Cardiff Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRDF, which in turn drives the price of the stock up even further. How often is Cardiff Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRDF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: X4 Pharmaceuticals Short Squeeze Vaxart Short Squeeze Cellectis Short Squeeze Cardiol Therapeutics Short Squeeze Compugen Short Squeeze Vigil Neuroscience Short Squeeze Genfit Short Squeeze Adverum Biotechnologies Short Squeeze Scilex Short Squeeze Omega Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRDF) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing